22nd Century Group is a plant biotechnology company focused on technology that allows Co. to alter the level of nicotine and other nicotinic alkaloids in tobacco plants and the levels of cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. Co.'s products include:Very Low Nicotine Content Cigarettes, which contains less nicotine to reduce smokers' exposure to nicotine, which is the primary addictive component of cigarettes under the product names of Moonlight® and Moonlight Menthol®; and SPECTRUM® Government Research Cigarettes, which supplies cigarettes with different nicotine contents (from very low to high) to National Institute on Drug Abuse. The XXII stock yearly return is shown above.
The yearly return on the XXII stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2017 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the XXII annual return calculation with any dividends reinvested as applicable (on ex-dates).
|